While speaking with CNBC, Bourla revealed that Pfizer is currently working on an Omicron-specific vaccine that will help to provide greater protection against the strain.
Drugmaker Pfizer beginning to see a decline in immunity rates of protection against the COVID -19 virus with their vaccine.